4.7 Article

Declining Walking Impairment Questionnaire Scores Are Associated With Subsequent Increased Mortality in Peripheral Artery Disease

期刊

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 61, 期 17, 页码 1820-1829

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2013.01.060

关键词

functional limitation; intermittent claudication; mortality; peripheral artery disease

资金

  1. National Heart, Lung, and Blood Institute [K12-HL083790, R01-HL083064, R01-HL64739, R01-HL71223]
  2. National Center for Research Resources, National Institutes of Health [RR-00048]
  3. National Institute on Aging

向作者/读者索取更多资源

Objectives This study determined whether greater 2-year declines in Walking Impairment Questionnaire (WIQ) stair climbing, distance, or speed scores were associated with higher all-cause and cardiovascular disease (CVD) mortality among men and women with lower extremity peripheral artery disease (PAD). Background Associations of decline in the WIQ with mortality among people with PAD are unknown. Methods Participants were 442 men and women with PAD identified from Chicago area medical centers. The WIQ was completed at baseline and at 2-year follow-up. Cox proportional hazard models were used to assess associations across categories of 2-year changes in WIQ stair climbing, WIQ distance, and WIQ speed scores with subsequent all-cause and CVD mortality, adjusting for age, sex, race, ankle-brachial index, body mass index, smoking, comorbidities, and other covariates. Results One hundred twenty-three participants (27.8%) died during a median follow-up of 4.7 years after the 2-year change in WIQ score measurements. Forty-five participants died from CVD. Adjusting for covariates, participants with WIQ score declines >= 20.0 points had higher all-cause mortality (hazard ratio [HR]: 1.93, 95% confidence interval [CI]: 1.01 to 3.68 for WIQ stair climbing; HR: 2.34, 95% CI: 1.15 to 4.75 for WIQ distance; and HR: 3.55, 95% CI: 1.57 to 8.04 for WIQ speed, respectively) compared with participants with >= 20.0 point improvement in each of the corresponding WIQ categories. Participants with >= 20.0 point declines in the WIQ distance score had higher CVD mortality (HR: 4.56, 95% CI: 1.30 to 16.01) compared with those with >= 20.0 point improvement in the WIQ distance score. Conclusions Patients with PAD who experienced >= 20.0 point declines in the WIQ stair climbing, distance, and speed scores had a higher rate of all-cause mortality compared with those with less declines in each WIQ score. (J Am Coll Cardiol 2013;61:1820-9) (C) 2013 by the American College of Cardiology Foundation

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Surgery

Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease

Madeline D. Cetlin, Tamar Polonsky, Karen Ho, Dongxue Zhang, Lu Tian, Lihui Zhao, Philip Greenland, Diane Treat-Jacobson, Melina R. Kibbe, Michael H. Criqui, Jack M. Guralnik, Mary M. McDermott

Summary: This study identified barriers to participation in supervised exercise therapy covered by CMS for lower extremity PAD. The majority of participants had never been prescribed or recommended supervised exercise therapy by their physicians, and most were unwilling or unable to pay the required copay for CMS-covered sessions. Many individuals also cited travel to medical centers as a significant obstacle to participation. These findings highlight the significant barriers faced by PAD patients in accessing and participating in supervised exercise therapy.

JOURNAL OF VASCULAR SURGERY (2023)

Article Clinical Neurology

Illusory Responses across the Lewy Body Disease Spectrum

Marian Shahid, Ashley Rawls, Veronica Ramirez, Sephira Ryman, Veronica E. Santini, Laurice Yang, Sharon J. Sha, Jacob N. Hall, Thomas J. Montine, Amy Lin, Lu Tian, Victor W. Henderson, Brenna Cholerton, Maya Yutsis, Kathleen L. Poston

Summary: This study aimed to investigate pareidolias in patients across the Lewy body disease spectrum. Illusory responses were studied in 300 participants, and it was found that cognitively impaired LB patients were more likely to endorse illusory responses compared to other groups. The Noise Pareidolia Task can be used to screen for unobtrusive pareidolias in LB patients before the onset of hallucinations and delusions.

ANNALS OF NEUROLOGY (2023)

Review Cardiac & Cardiovascular Systems

Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event-Moving Beyond C Statistic A Review

Xuan Wang, Brian Lee Claggett, Lu Tian, Marcus Vinicius Bolivar Malachias, Marc A. Pfeffer, Lee-Jen Wei

Summary: For personalized or stratified medicine, it is crucial to establish a reliable and efficient prediction model for a clinical outcome of interest. However, commonly used metrics like C statistics do not accurately assess the model's prediction accuracy. This article highlights the importance of finding a clinically interpretable measure that quantifies prediction accuracy for improved model selection and evaluation.

JAMA CARDIOLOGY (2023)

Article Mathematics

Improving the Robustness of Variable Selection and Predictive Performance of Regularized Generalized Linear Models and Cox Proportional Hazard Models

Feng Hong, Lu Tian, Viswanath Devanarayan

Summary: High-dimensional data applications require the use of statistical and machine-learning algorithms to identify optimal biomarker signatures based on patient characteristics for predicting clinical outcomes in biomedical research. Regularization, particularly L-1-based regularization, is commonly used to improve prediction performance and feature selection. However, choosing the penalty parameter for regularization can be unstable and may lead to inflated predictive performance estimates. This paper proposes a Monte Carlo approach for robust regularization parameter selection and an additional cross-validation wrapper for objectively evaluating the final model's predictive performance.

MATHEMATICS (2023)

Letter Medicine, General & Internal

Assessment of Median and Mean Survival Time in Cancer Clinical Trials

Ananya Das, Timothy A. Lin, Christine Lin, Tomer Meirson, Zachary R. McCaw, Lu Tian, Ethan B. Ludmir

JAMA NETWORK OPEN (2023)

Article Oncology

Altered expression of the L-arginine/nitric oxide pathway in ovarian cancer: metabolic biomarkers and biological implications

Linfeng Chen, Qiming Tang, Keying Zhang, Qianyang Huang, Yun Ding, Bo Jin, Szumam Liu, Kuoyuan Hwa, C. James Chou, Yani Zhang, Sheeno Thyparambil, Weili Liao, Zhi Han, Richard Mortensen, James Schilling, Zhen Li, Robert Heaton, Lu Tian, Harvey J. Cohen, Karl G. Sylvester, Rebecca C. Arent, Xinyang Zhao, Doff B. Mcelhinney, Yumei Wu, Wenpei Bai, Xuefeng B. Ling

Summary: This study explores the potential use of metabolic changes as biomarkers for assessing ovarian cancer. The research identifies key gene expression pathways and proposes symmetric dimethylarginine (SDMA) and arginine as potential liquid biopsy biomarkers for ovarian cancer assessment.

BMC CANCER (2023)

Editorial Material Urology & Nephrology

Using Restricted Mean Survival Time to Improve Interpretability of Time-to-Event Data Analysis

Vivek Charu, Lu Tian, Manjula Kurella Tamura, Maria E. Montez-Rath

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Pharmacology & Pharmacy

Hybrid Controlled Clinical Trials Using Concurrent Registries in Amyotrophic Lateral Sclerosis: A Feasibility Study

Ruben P. A. van Eijk, Leonard H. H. van den Berg, Kit C. B. Roes, Lu Tian, Tze L. L. Lai, Lorene M. M. Nelson, Chenyu Li, Anna Scowcroft, Jesus Garcia-Segovia, Ying Lu

Summary: Hybrid designs with both randomized arms and an external control cohort are proposed to enhance clinical trials by using concurrent registries. The methodology was evaluated in a randomized, placebo-controlled clinical trial for amyotrophic lateral sclerosis. Matching eligible external controls from a different calendar period led to bias in the treatment effect estimate. Hybrid trial designs utilizing a concurrent registry with rigorous matching can minimize bias and accelerate the development of new treatments.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Article Developmental Biology

Evaluation of C4 gene copy number in Pediatric Acute Neuropsychiatric Syndrome

Agnieszka Kalinowski, Lu Tian, Reenal Pattni, Hanna Ollila, Maroof Khan, Cindy Manko, Melissa Silverman, Meiqian Ma, Laurie Columbo, Bahare Farhadian, Susan Swedo, Tanya Murphy, Mats Johnson, Elisabeth Fernell, Christopher Gillberg, Margo Thienemann, Elizabeth D. Mellins, Douglas F. Levinson, Alexander E. Urban, Jennifer Frankovich

Summary: Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is a sudden-onset neuropsychiatric disorder with an increased prevalence of co-morbid autoimmune illness, particularly arthritis. PANS patients with low C4B copy number are at higher risk for subsequent Juvenile Idiopathic Arthritis (JIA) diagnosis. There is a possible association between low C4B and PANS age of onset, suggesting a potential role of C4B in different types of arthritis.

DEVELOPMENTAL NEUROSCIENCE (2023)

Article Immunology

Low-dose naltrexone use for the management of post-acute sequelae of COVID-19

Hector Bonilla, Lu Tian, Vincent C. Marconi, Robert Shafer, Grace A. Mccomsey, Mitchel Miglis, Philip Yang, Andres Bonilla, Lauren Eggert, Linda N. Geng

Summary: The global prevalence of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) is approximately 43%, while in the United States, around 11% of individuals who have been infected with SARSCoV-2 experience long COVID. The underlying causes of PASC are still under investigation, and there are currently no FDA-approved therapies. Naltrexone, a medication with anti-inflammatory and immunomodulatory properties, has shown potential as a therapeutic intervention for PASC, but further rigorous clinical trials are needed.

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

Letter Oncology

Evaluating the Duration of Response With Mirvetuximab Soravtansine for Treating Platinum-Resistant Ovarian Cancer

Zachary R. Mccaw, Lu Tian, Lee-Jen Wei

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Medicine, General & Internal

Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery Disease An Individual Participant Data Meta-Analysis

Neela D. Thangada, Dongxue Zhang, Lu Tian, Lihui Zhao, W. Jack Rejeski, Karen J. Ho, Luigi Ferrucci, Bonnie Spring, Melina R. Kibbe, Tamar S. Polonsky, Michael H. Criqui, Mary M. Mcdermott

Summary: In this meta-analysis of individual participant data, home-based walking exercise was found to improve 6-minute walk more than supervised treadmill exercise in people with PAD. These findings support home-based walking exercise as a first-line therapy for walking limitations in PAD.

JAMA NETWORK OPEN (2023)

Article Clinical Neurology

Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry

Xiaotong Jiang, Gabrielle Simoneau, Mel Zuercher, Yanic Heer, Philip van Hoevell, Adrian Harrington, Wanda Castro-Borrero, Carl de Moor, Fabio Pellegrini, Lu Tian, Arnfin Bergmann, Stefan Braune

Summary: This retrospective study assessed the overall and patient-specific effects of dimethyl fumarate (DMF) versus teriflunomide (TERI) in patients with relapsing-remitting multiple sclerosis (MS). The study utilized a precision medicine scoring approach and found that DMF had superior effectiveness in reducing relapse-related endpoints compared to TERI. Furthermore, the study identified a subgroup of patients for whom DMF was more effective than TERI.

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2023)

Letter Cardiac & Cardiovascular Systems

Use the Receiver Operating Characteristic to Assess Model Accuracy Reply

Xuan Wang, Brian Lee Claggett, Lu Tian

JAMA CARDIOLOGY (2023)

Meeting Abstract Peripheral Vascular Disease

Ischemic leg symptom severity and response to supervised exercise in peripheral artery disease (PAD): results from three randomized clinical trials

Mary O. Whipple, Lihui Zhao, Lu Tian, Dongxue Zhang, Mary M. McDermott

VASCULAR MEDICINE (2023)

暂无数据